[Close]
- This page was created by volunteers like you!
- Help us make it even better. To learn more about contributing to MEpedia, click here.
- Join the movement
- Visit #MEAction to find support or take action. Donate today to help us improve and expand this project.
- Congratulations!
- MEpedia has got over 30 million views as of August 2022!
Matthew Morris
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Matthew C. Morris, PhD, researches at Gosnell School of Life Sciences, Rochester Institute of Technology, Rochester, NY, US and Center for Clinical Systems Biology, Rochester General Hospital, Rochester, NY, US.
Research studies[edit | edit source]
- 2018, High-fidelity discrete modeling of the HPA axis: a study of regulatory plasticity in biology[1] (Abstract)
- 2019, Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome[2] (Abstract)
- 2019, Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary[3] (Abstract)
Online presence[edit | edit source]
References[edit | edit source]
- ↑ Sedghamiz, Hooman; Morris, Matthew; Craddock, Travis J.A.; Whitley, Darrell; Broderick, Gordon (July 17, 2018). "High-fidelity discrete modeling of the HPA axis: a study of regulatory plasticity in biology". BMC Systems Biology. 12 (76). doi:10.1186/s12918-018-0599-1.
- ↑ Morris, Matthew C.; Cooney, Katherine E.; Sedghamiz, Hooman; Abreu, Maria; Collado, Fanny; Balbin, Elizabeth G.; Craddock, Travis J.A.; Klimas, Nancy G.; Broderick, Gordon; Fletcher, Mary Ann (March 2019). "Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome". Clinical Therapeutics. doi:10.1016/j.clinthera.2019.03.002.
- ↑ Richman, Spencer; Morris, Matthew C.; Broderick, Gordon; Craddock, Travis J.A.; Klimas, Nancy G.; Fletcher, Mary Ann (March 2019). "Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary". Clinical Therapeutics. doi:10.1016/j.clinthera.2019.02.011.
